(3)Commission Implementing Regulation (EU) 2023/2592note extended the approval period of the active substance 8-hydroxyquinoline until 31 December 2024.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.
law://eu/reg/2024/2781/rct_3@2026-11-11Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.